Skip to content
411 PRESS

Recall Database

Medline Industries Recalls

Recalled Medline Bed Assist Bar adult bed rails

Medline Bed Assist Bar adult bed rails (recalled). Photo: CPSC / Public Domain.

Recalls in database
135
Agency
FDA 134 · CPSC 1
Years covered
2024–2026

Medline Industries is the largest brand grouping on the site with 135 recall records, and one of only two that span more than one regulator. Its records come from both the CPSC and the FDA — a reflection of its range across consumer and medical products. In the site's hazard taxonomy, 91 of the records classify as medical-device defects and 42 as drug or medical-product contamination.

Almost all of these notices — 134 of 135 — were published in 2026, which tracks the current FDA and CPSC ingestion window rather than Medline's full recall history. Read the scope note below before reading the count as a total.

Use this hub to see every Medline recall in the dataset in one place. Each row links to the original CPSC or FDA notice with the affected product, lot information, and the firm's corrective action.

135 recall records
Years 2024–2026
By agency FDA 134 · CPSC 1
Data through Mar 24, 2026

How this hub is built. This page collects the 135 recall records tied to Medline Industries in the current 411 Press recall dataset. Records are grouped by a normalized version of the recalling firm's name (normalizer version 2026-07-28.C3.2). Parent, subsidiary, and "doing business as" relationships are not merged unless the agency data states them, so a corporate family can appear under more than one name. Regulators for these records: CPSC and FDA. They were published 2024–2026. A recall count reflects how much recall activity fell inside the ingestion window — roughly February 2023 through May 2026, refreshed late May 2026 — not a ranking of relative safety. Larger manufacturers and higher-volume product lines file more notices. This is the current dataset, not an all-time total, and it grows as new notices are ingested. Every row links to the original agency notice.

2026 (134)

  • FDAClass I

    Namic Preceptor Manifold

    Medline has identified the presence of particulate within the fluid path of the Manifolds.

  • FDAClass I

    Namic Preceptor Manifold

    Medline has identified the presence of particulate within the fluid path of the Manifolds.

  • FDAClass I

    Namic Angiographic Manifold

    Medline has identified the presence of particulate within the fluid path of the Manifolds.

  • FDAClass I

    Namic Angiographic Manifold

    Medline has identified the presence of particulate within the fluid path of the Manifolds.

  • FDAClass I

    Namic Angiographic Manifold

    Medline has identified the presence of particulate within the fluid path of the Manifolds.

  • FDAClass I

    Medline medical convenience kits

    Medline has identified the presence of particulate within the fluid path of the Manifolds.

  • FDAClass I

    Medline medical convenience kits, containing Namic Manifold, Labeled as: 1.

    Medline has identified the presence of particulate within the fluid path of the Manifolds.

  • FDAClass I

    Medline medical convenience kits

    Medline has identified the presence of particulate within the fluid path of the Manifolds.

  • FDAClass I

    Medline medical convenience kits, containing Namic Manifold, Labeled as: 1.

    Medline has identified the presence of particulate within the fluid path of the Manifolds.

  • FDAClass I

    1.

    Medline has identified the presence of particulate within the fluid path of the Manifolds.

  • FDAClass I

    1.

    Medline has identified the presence of particulate within the fluid path of the Manifolds.

  • FDAClass II

    Medline Neuro Sponges, various dimensions, labeled as: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits, containing Medline Neuro Sponges, labeled as follows: 1.

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline and Centurion medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Centurion medical procedure kits

    During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.

  • FDAClass II

    Medline or Centurion medical convenience kits, containing Webcol Large Alcohol Prep Pads, labeled as: 1.

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    Medline medical convenience kits, containing Webcol Large Alcohol Prep Pads, labeled as: 1.

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    Medline and Centurion medical convenience kits, containing Webcol Large Alcohol Prep Pads, labeled as: 1.

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    Medline and Centurion medical convenience kits, containing Webcol Large Alcohol Prep Pads, labeled as: 1.

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    Centurion medical convenience kits

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    Centurion medical convenience kits

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    Centurion medical convenience kits

    Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing Cardinal Health Webcol Large Alcohol Prep Pads. Cardinal Health has deemed Webcol Large Alcohol Prep Pads to be non-sterile following the discovery of a contaminant (Paenibacillus phoenicis) during a routine sterilization dose audit.

  • FDAClass II

    CENTURION Circumcision Kit

    On lot of Sterile Circumcision Kits was distributed without the required sterilization process and is therefore not sterile.

  • FDAClass I

    NAMIC Angiographic Control Syringe, labeled as follows: 1.

    Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass I

    Medline medical convenience kits

    Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass I

    Medline medical convenience kits

    Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes ENSEMBLE GYNECO SCOPIE-LF

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes ARTERIOGRAM TRAY 00-402001T

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes ADD A ENDOVASCULAR PACK-LF

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes E P DRAPE PACK-LF DYNJ0373061J

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes ARTHROSCOPY PACK DYNJ45173D

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes EXTREMITY PACK DYNJ34846C

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes EYE PACK DYNJ35056A

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes GU DAVINCI PACK - LF

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes ANGIO KIT PACK DYNJ50783B

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes Medline Convenience Kits

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes FACE/RHINOPLASTY PACK

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes BARIATRIC DYNJ905153M

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes MINOR ENT SINUS PACK-LF

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes BIOPSY PACK DYNJ38587A

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes TAVR PACK DYNJ69246B

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes ADULT CATH PACK-LF

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Convenience Kits containing select SKUs of 10mL Polycarbonate Colored Syringes JUDKINS PACK DYNJ51126

    Unapproved design changes to the products outside of the 510(k) clearance.

  • FDAClass II

    Medline Syringes: 1) SYRINGE 12ML CONTROL W/ROTATOR

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Namic Syringes: 1) SYR CNTRL 10ML RING W/ROT NB

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Namic Guidewires: 1) GUIDEWIRE 3MMJ 0.035X260CM LT

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) SYR CONTROL 8ML ROTATING

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) SYR CNTRL 10ML RING W/ROT NB

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) PICC TRAY

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) NEWBORN ADMISSION

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) MTS LEFT HEART KIT-CAROLINAS HOS, Model Number: 60021775; 2) DBD-MTS LHK BHS BAPTIST.

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) LABOR PACK-22025208-LF

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) HYSTEROSCOPY PACK

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) HEART TRANSPLANT BIOPSY

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) GYN LAPAROSCOPY PACK

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) GENERAL LAPAROSCOPY

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) ENT PACK

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) D AND C PACK

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) CATH LAB CDS

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) BWNBORO CRANIOTOMY PACK-LF

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) BREAST PACK

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) ARTHROSCOPY PACK

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) ARTHROGRAM TRAY

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) ANGIOGRAPHY PACK-LF

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    Medline Kits: 1) ANGIO CATH PACK-MARY IMMACULAT

    The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.

  • FDAClass II

    See RES for full list.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See RES for complete list.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See RES for complete list.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See RES for complete list.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See RES for complete list.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See RES for complete list.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See full list in RES

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    See complete list in RES, exceeds character limit.

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Surgical Packs: 1) PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Surgical Drapes: 1) SHEET

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) WMC I D PACK-LF

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) SCC RF PAIN MGMT

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) PPE KIT

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) PICC LINE TRAY

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) PICC CATHETER INSERTION TRAY

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) OB KIT

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) NEURO SHUNT- CODMAN

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) LVAD DRIVELINE TRAY

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) LITHOTOMY PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) KIT UROLOGY SLING

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) KIT TRIPLE LUMEN INSERTION

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) KIT SURG ONC EXCISION BREAST

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) KIT STC TRACHEOSTOMY

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) KIT OPHTHALMIC RUPTURE GLOBE

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) KIT GENERAL CLOSURE

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) HYSTEROSCOPY

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) DYNDA3003

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) DRAPE PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) DRAPE PACK-CHOICE

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) CVC PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) CHEST TUBE INSERTION TRAY

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) CENTRAL LINE UNIVERSAL INSERTI

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) C-SECTION PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) BURN PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) BASIC NERVE BLOCK TRAY W/LINEN

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) BAPTIST FLOYD ENDO GI KIT

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) BAP NORTH ROBOTIC SURGERY CDS

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) ARTHROSCOPY CDS

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) ANGIO PROCEDURE PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) ANGIO PROCEDURE PACK

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) ANCILLARY PACK-LF

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

  • FDAClass II

    Medline Convenience Kits: 1) ADMIT KIT

    Medline has identified issues related to calibration of the equipment used to sterilize and package the devices. All products were exposed to the validated sterilization and packaging cycles; however, the identified calibration issues have the potential to impact the sterility assurance level (SAL) of the Recalled Products.

2024 (1)

  • CPSCCritical

    Medline Bed Assist Bar adult bed rails

    When the recalled bed rails are attached to an adult's bed, users can become entrapped within the bed rail or between the bed rail and the side of the mattress. This poses a serious entrapment hazard and risk of death by asphyxiation.

Independent news on labor, safety, and accountability.